Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Neurocrine Biosciences (NBIX) Other Non-Current Assets: 2010-2020

Historic Other Non-Current Assets for Neurocrine Biosciences (NBIX) over the last 11 years, with Dec 2020 value amounting to $6.4 million.

  • Neurocrine Biosciences' Other Non-Current Assets fell 99.25% to $3.2 million in Q3 2021 from the same period last year, while for Sep 2021 it was $3.2 million, marking a year-over-year decrease of 99.25%. This contributed to the annual value of $6.4 million for FY2020, which is 94.46% down from last year.
  • Per Neurocrine Biosciences' latest filing, its Other Non-Current Assets stood at $6.4 million for FY2020, which was down 94.46% from $115.5 million recorded in FY2019.
  • In the past 5 years, Neurocrine Biosciences' Other Non-Current Assets registered a high of $115.5 million during FY2019, and its lowest value of $4.5 million during FY2017.
  • Moreover, its 3-year median value for Other Non-Current Assets was $6.4 million (2020), whereas its average is $42.5 million.
  • Its Other Non-Current Assets has fluctuated over the past 5 years, first spiked by 2,008.82% in 2019, then tumbled by 94.46% in 2020.
  • Yearly analysis of 5 years shows Neurocrine Biosciences' Other Non-Current Assets stood at $4.9 million in 2016, then fell by 7.84% to $4.5 million in 2017, then rose by 21.71% to $5.5 million in 2018, then surged by 2,008.82% to $115.5 million in 2019, then tumbled by 94.46% to $6.4 million in 2020.